We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
REVIEW
[Treatment of insulin-dependent diabetes: new therapeutics. Cellular replacement: facts and perspectives].
The replacement of insulin producing beta cells by islet transplantation can effectively control blood glucose levels in individuals with Type I diabetes. Recent improvements in clinical results were made possible by transplantation of greater islet masses and introduction of new immunosuppressive protocols, which avoid diabetogenicity. Future, widespread clinical application of islet transplantation will depend on the availability of an unlimited source of glucose sensitive, insulin-secreting tissue and less toxic immunosuppressors.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app